Drug Shortage Report for AURO-OLANZAPINE ODT

Last updated on 2022-02-09 History
Report ID 56346
Drug Identification Number 02448734
Brand name AURO-OLANZAPINE ODT
Common or Proper name OLANZAPINE
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 3X10
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-25
Estimated end date 2022-02-10
Actual end date 2022-01-07
Shortage status Resolved
Updated date 2022-02-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-24 English Compare
v2 2018-07-24 French Compare
v3 2018-07-26 English Compare
v4 2018-09-28 English Compare
v5 2018-09-28 French Compare
v6 2018-10-03 English Compare
v7 2018-10-03 French Compare
v8 2018-10-12 English Compare
v9 2018-10-12 French Compare
v10 2018-11-13 English Compare
v11 2018-11-13 French Compare
v12 2018-11-13 English Compare
v13 2018-11-13 French Compare
v14 2018-12-21 English Compare
v15 2018-12-21 English Compare
v16 2018-12-21 French Compare
v17 2019-01-14 English Compare
v18 2019-01-14 French Compare
v19 2019-01-24 English Compare
v20 2019-01-24 French Compare

Showing 1 to 20 of 44